Nan Li

Nan Li is an Associate Principal Scientist at AstraZeneca, where they lead efforts to characterize novel CAR-T platforms and investigate approaches to enhance CAR-T efficacy in solid tumors. With a PhD in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham, Nan has extensive experience in cell therapy, antibody drug discovery, and cancer biology. They previously held roles as a postdoctoral fellow at the National Cancer Institute and as a staff scientist, leading preclinical CAR-T programs and contributing to numerous patents and publications. Nan's collaborative spirit and project management skills have fueled productive research in competitive areas, showcasing their commitment to advancing cancer therapies.